|Podcast Available At:
Thomas Busby, Vice President at Outcome Capital, joins host, Giovanni Lauricella, to discuss what an investment banker can do for a MedTech start-up and how they can help work strategics.
For more information, please contact
BOSTON–(BUSINESS WIRE)–Outcome Capital, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that ELIOS Vision, Inc. completed a growth financing round to support its European commercialization. Outcome Capital served as the exclusive strategic and financial advisor to the company. ELIOS’ implant-free, minimally invasive Excimer Laser Trabeculostomy glaucoma procedure is approved […]Read More
Outcome Capital Life Science Market Pulse May 2022 Click to view our LifeSciences Pulse NewsletterDownload